04/18/2024
3:30 PM | Singular Genomics Systems (Filer)
| Form DEF 14A | |
04/18/2024
3:31 PM | Singular Genomics Systems (Filer)
| Form DEFA14A | |
04/18/2024
3:32 PM | Singular Genomics Systems (Filer)
| Form ARS | |
04/05/2024
3:30 PM | Singular Genomics Systems (Filer)
| Form PRE 14A | |
03/19/2024
4:46 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
4:47 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
4:48 PM | Meeter Dalen (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/19/2024
4:49 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:01 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:02 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:03 PM | Meeter Dalen (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:04 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
5:05 PM | Ghai Jyotsna (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
4:31 PM | Flynn James E (Filed by)
Singular Genomics Systems (Subject)
| Form SC 13G/A | |
01/19/2024
3:29 PM | Singular Genomics Systems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
5:01 AM | Singular Genomics Systems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2023
4:41 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:42 PM | Meeter Dalen (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:44 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:39 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:30 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:31 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/14/2023
3:16 PM | Singular Genomics Systems (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/09/2023
4:30 PM | Ghai Jyotsna (Reporting)
Singular Genomics Systems (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
09/15/2023
6:01 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
6:01 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
6:02 PM | Meeter Dalen (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
6:03 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:36 PM | Singular Genomics Systems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/17/2023
3:31 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
6:17 PM | Kamdar Kim P. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2023
4:07 PM | Flynn James E (Filed by)
Singular Genomics Systems (Subject)
| Form SC 13G/A | |
08/14/2023
3:31 PM | Kamdar Kim P. (Reporting)
Singular Genomics Systems (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
3:30 PM | Singular Genomics Systems (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/20/2023
4:04 PM | Singular Genomics Systems (Issuer)
Spaventa Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
4:05 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
4:08 PM | Meeter Dalen (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
4:09 PM | Ropp Sam (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/18/2023
7:32 PM | Glezer Eli N. (Reporting)
Singular Genomics Systems (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
